Abstract
To investigate the sensitivity of ovary to follicle-stimulating hormone (FSH) during the early follicular phase of the human menstrual cycle in patients with Down Syndrome (DS) six post-menarchal patients with Down Syndrome and twelwe normoovulatory women were studied. Randomly, DS patients were submitted in two consecutive cycles to a treatment with GH (0.1 IU/Kg im) or saline for 3 days. Pure FSH (75 IU) was given iv at day 3 and plasma levels of LH, FSH, E2, Testosterone, DHEAS, Androstenedione, GH and IGF-I were assayed in samples collected for a period of 26h after the injection. Data were compared with those obtained from controls receiving pure FSH or saline. In control patients FSH injection increased E2 stimulated area under curve (AUC). This value was significantly greater than that found in DS patients, who exhibited an E2-stimulated AUC superimposable to saline treated controls. In DS GH plasma concentrations were significantly lower than in control group (p<0.05). The treatment with GH is able to normalize the ovarian response to FSH in DS patients at levels similar to those found in FSH treated controls. Moreover in GH treated cycles, both GH and IGF-I plasma concentrations were higher at time of FSH injection with respect to those found in the cycles where saline was given. These results indicate that the ovarian sensitivity to FSH in patients with DS is blunted. Lower GH plasma levels found in this group may in part account for this biological feature, since GH treatment is able to restore the ovarian response, probably via an increase of IGF-I plasma concentrations.
Similar content being viewed by others
References
Katz E., Ricciarelli E., Adashi E.Y. The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil. Steril. 59: 8, 1993.
Tanner J.M., Whithous R.H. A note on the bone age at which patients with true isolated growth hormone deficiency enter puberty. J. Clin. Endocrinol. Metab. 41: 788, 1975.
Kulin E., Samojlik E., Santen R., Santner S. The effect of gonadotropin in boys with Hypopituitarism. Clin. Endocrinol. (Oxf.) 15: 463, 1981.
Hasen J., Boyar R.M., Shapiro L.R. Gonadal function in trisomy 21. Horm. Res. 12: 345, 1980.
Hsiang Y.H., Berkovitz G.D., Bland G.L., Migeon C.J., Warren A.C. Gonadal function in patients with Down Syndrome. Am. J. Med. Genet. 27: 449, 1987.
Bellone E., Tanganelli E., La Placa A., Daneri C. Menarca e fisiopatologia mestruale nella sindrome di Down. Minerva Ginecol. 32: 579, 1980.
Tricomi V., Valenti C., Hall J.E. Ovulatory patterns in Down’s Syndrome. Obstet. Gynecol. 89: 651, 1964.
Scola P.S., Pueschel S.M. Menstrual cycles and basal body temperature curves in women with Down syndrome. Obstet. Gynecol. 79: 91, 1992.
Rani A.S., Jyothi A., Reddy P.P., Reddy O.S. Reproduction in Down’s Syndrome. Int. J. Gynaecol. Obstet. 31: 81, 1990.
Cento R.M., Ragusa L., Proto C., Alberti A., Romano C., Boemi G., Colabucci F., Lanzone A. Basal body temperature curves and endocrine pattern of menstrual cycles in Down Syndrome. Gynecol. Endocrinol. 10: 133, 1996.
Caruso A., Fortini A., Fulghesu A.M., Pistilli E., Cucinelli F., Lanzone A., Mancuso S. Ovarian sensitivity to follicle-stimulating hormone during the follicular phase of the human menstrual cycle and in patients with polycistic ovarian syndrome. Fertil. Steril. 59: 115, 1993.
Cento R.M., Ragusa L., Proto C., Alberti A., Fiore G., Colabucci F., Lanzone A. The ovarian sensitivity to follicle-stimulating hormone is blunted in normoovulatory women with Down Syndrome. Hum. Reprod. 12: 1709, 1997.
Ragusa L., Alberti A., Proto C., Romano C., Colabucci F. Recombinant human growth-hormone treatment in Down Syndrome: the Troina experience. Developmental Brain Dysfunction 9: 158, 1996.
Benda C.E. Down’s Syndrome. Grune and Stratton, New York, 1969.
Zeleznik A.J. Premature elevation of systemic estradiol reduces serum levels of follicle-stimulating hormone and lengthens the follicular phase of the menstrual cycle in Rhesus monkeys. Endocrinology 109: 352, 1981.
Zeleznik A.J., Kubik C.J. Ovarian responses in macaques to pulsatile infusion of follicle-stimulating hormone (FSH) and luteinizing hormone: increased sensitivity of the maturing follicle to FSH. J. Clin. Endocrinol. Metab. 119: 2025, 1986.
Messinis I.E., Templeton A.A. The importance of follicle-stimulating hormone increase for folliculogenesis. Hum. Reprod. 5: 153, 1990.
Cronk C.E., Crocker A.C., Pueschel S.M., Sher A.M., Zockai E., Pickens G. Growth charts for children with Down’s Syndrome: 1 month to 18 years of age. Pediatrics 81: 102, 1988.
Bates G.W., Whitworth N.S. Effect of body weight reduction on plasma androgens in obese infertile women. Fertil. Steril. 53: 254, 1982.
Mason H.D, Mertikainen H., Beard R.W., Anyaoku V., Franks S. Direct gonadotrophic effect of growth hormone on estradiol production by human granulosa cells in vitro. J. Endocrinol. R, 1–4. (abstract) 1990.
Jia X., Kalmijn J., Hsueh A.J.W. Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology 118: 1401, 1986.
Homburg R., Eshel A., Abdalla H.I., Jacobs H.S. Growth hormone facilitates ovulation induction by gonadotrophins. Clin. Endocrinol. (Oxf.) 29: 113, 1988.
Apa R., Lanzone A., Miceli F., Caruso A., Mancuso S., Canipari R. Growth hormone induction of rat granulosa cell tissue-plasminogen activator expression and progesterone synthesis. Mol. Cell. Endocrinol. 99: 153, 1994.
Adashi E.Y., Resnik C.E., D’Ercole A.J., Svoboda M.E., Van Wyk J.J. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr. Rev. 6: 400, 1985.
Lanzone A., Fortini A., Fulghesu A.M., Soranna L., Caruso A., Mancuso S. Growth-hormone enhances estradiol production follicle-stimulating hormone-induced in the early stage of the follicular maturation. Fertil. Steril. 66: 948, 1996.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cento, R.M., Ragusa, L., Proto, C. et al. Growth hormone administration normalizes the ovarian responsiveness to follicle-stimulating-hormone in the early stages of the follicular maturation in women with Down Syndrome. J Endocrinol Invest 21, 342–347 (1998). https://doi.org/10.1007/BF03350768
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350768